Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study

Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder

(2014) T Hermanns et al.   BRITISH JOURNAL OF CANCER

Inflammatory Biomarkers and Bladder Cancer Prognosis: A Systematic Review

(2014) Alexandra Masson-Lecomte et al.   EUROPEAN UROLOGY

Pretreatment Neutrophil-to-Lymphocyte Ratio Is Associated with Advanced Pathologic Tumor Stage and Increased Cancer-specific Mortality Among Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

(2014) Boyd R. Viers et al.   EUROPEAN UROLOGY

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

(2014) Arnoud J. Templeton et al.   JNCI-Journal of the National Cancer Institute

Bladder cancer invasion predictability based on preoperative neutrophil–lymphocyte ratio

(2014) Mehmet Kaynar et al.   TUMOR BIOLOGY

NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder

(2014) Aaron Potretzke et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Considerations on the use of urine markers in the management of patients with high-grade non–muscle-invasive bladder cancer

(2014) Ashish M. Kamat et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Micro RNA expression and prognosis in low-grade non-invasive urothelial carcinoma

(2014) Nelson Dip et al.   International Braz J Urol

Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer

(2014) Jun Zhao et al.   International Braz J Urol

Incidence and clinical characteristics of lower urinary tract symptoms as a presenting symptom for patients with newly diagnosed bladder cancer

(2014) Ryan W. Dobbs et al.   International Braz J Urol

The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer

(2013) Graeme J.K. Guthrie et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

(2013) Marko Babjuk et al.   EUROPEAN UROLOGY

Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial

(2013) P. Gkritsios et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer

(2012) M J Proctor et al.   BRITISH JOURNAL OF CANCER

Pretreatment Parameters Obtained from Peripheral Blood Sample Predicts Invasiveness of Bladder Carcinoma

(2012) C. Can et al.   UROLOGIA INTERNATIONALIS

Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical Cystectomy

(2012) Tatsuo Gondo et al.   UROLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

(2010) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY